Skip to content

PROPOSAL FOR SYMPOSIUM –ANCIPS, 2022 The New Era Of Psychedelic (Hallucinogen) Associated Treatments In Psychiatry-Will It Be A Game Changer?

Jassar Abdul Jabbar, A. Ayyappan

Indian Journal of Psychiatry March 1, 2022 DOI: 10.4103/0019-5545.341834 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Key findings Psychedelic research was halted by a global ban but has seen renewed interest in the 21st century.

Abstract

Twenty first century is witnessing a renewed interest in the area of psychedelic(hallucinogen) research . In western countries ,even though researches were conducted in this area as early as 1930s, subsequent ban on psychedelic molecules across the world due to widespread use and reported side effects halted the prospects of such researches. This presentation seeks to explore the past history of psychedelic research, the subsequent ban ,the neurobiological underpinnings of psychedelics, the potential forms of psychedelic associated treatments currently being researched and future trends. •Primary author’s contact details: 1.Dr Jigyansa Ipsita Pattnaik, MD, DNB PDF (St Johns), Assistant Professor, Department of Psychiatry, Kalinga Institute of Medical Sciences (KIMS), KIIT University, Bhubaneswar, Odisha, India. drjigyansaipsita@gmail.com , Phone No- +91-8093-515161 •Details: Author and co-authors’ details 2.Dr Susanta Kumar Padhy, Additional Professor, Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India. 3.Dr Jigyansa Ipsita Pattnaik, MD, DNB PDF (St Johns), Assistant Professor, Department of Psychiatry, Kalinga Institute of Medical Sciences (KIMS), KIIT University, Bhubaneswar, Odisha, India. 4.Dr Jay Prakash Russell Ravan, MD (CMC Vellore), Professor, Department of Psychiatry, Kalinga Institute of Medical Sciences (KIMS), KIIT University, Bhubaneswar, Odisha, India.